Optical Coherence Tomography Angiography Characteristics Serve as Retinal Vein Occlusion Therapeutic Biomarkers for Dexamethasone Intravitreal Implant

<div>Comparison of vessel density and other related parameters. (a, b) Changes in retinal vessel density (a) and retinal thickness (b) at different regions of macula between baseline and post-injection. (c)-(e) Comparison of FAZ area (c), FAZ perimeter (d), and FD-300 (e) between baseline and post-injection. ns: not significant; FAZ: foveal avascular zone; FD-300: foveal vessel density within a 300 <i>μ</i>m wide region of FAZ.</div>

Disease Markers

fig8

Figure 8

Figure 8: Optical Coherence Tomography Angiography Characteristics Serve as Retinal Vein Occlusion Therapeutic Biomarkers for Dexamethasone Intravitreal Implant 

Figure 8 | Optical Coherence Tomography Angiography Characteristics Serve as Retinal Vein Occlusion Therapeutic Biomarkers for Dexamethasone Intravitreal Implant 